Blue-enriched polychromatic light
Blue-enriched polychromatic light has been studied in 1 paper since 2021: 1 trial in people. The newest paper, Feb 26, 2021: “Age-related neuroendocrine and alerting responses to light”.
1 paper studies it4 findingsUpdated
See all 1 papers on blue-enriched polychromatic light
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“In young individuals, light exposure at 6500 K significantly attenuated the increase in endogenous melatonin levels”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Axa Research Fund
- 4 of 4 findings with company ties
- Human trial1
Studies in people
1 study gave blue-enriched polychromatic light to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases melatonin down: Decreases subjective sleepiness up: Improves sustained attention | Trial2 h | 31 peopleBoth18-30 yearsOlder adults; young adults | GeroScience, Feb 26, 2021 |
What did studies of blue-enriched polychromatic light find?
4Studies of blue-enriched polychromatic light measured 4 outcomes, among them frontal slow-wave activity, sustained attention and subjective sleepiness.
Frontal slow-wave activity
downin humans1
1 study
Frontal slow-wave activity
downin humans1
Blue-enriched polychromatic light decreases frontal slow-wave activity in humans (young adults; compared with non-blue-enriched light).
“light exposure at 6500 K significantly attenuated the increase in endogenous melatonin levels, improved subjective sleepiness and sustained attention performance, and decreased frontal slow-wave activity”
Human trialyoung adults; compared with non-blue-enriched light6500 K~40 lx2 hn = 31
Age-related neuroendocrine and alerting responses to light
GeroScience
Sustained attention
upin humans1
1 study
Sustained attention
upin humans1
Blue-enriched polychromatic light improves sustained attention in humans (young adults; compared with non-blue-enriched light).
“In young individuals, light exposure at 6500 K significantly attenuated the increase in endogenous melatonin levels, improved subjective sleepiness and sustained attention performance”
Human trialyoung adults; compared with non-blue-enriched light6500 K~40 lx2 hn = 31
Age-related neuroendocrine and alerting responses to light
GeroScience
Subjective sleepiness
downin humans1
1 study
Subjective sleepiness
downin humans1
Blue-enriched polychromatic light decreases subjective sleepiness in humans (young adults; compared with non-blue-enriched light).
“In young individuals, light exposure at 6500 K significantly attenuated the increase in endogenous melatonin levels, improved subjective sleepiness and sustained attention performance”
Human trialyoung adults; compared with non-blue-enriched light6500 K~40 lx2 hn = 31
Age-related neuroendocrine and alerting responses to light
GeroScience
Melatonin
downin humans1
1 study
Melatonin
downin humans1
Blue-enriched polychromatic light decreases melatonin in humans (young adults; compared with non-blue-enriched light).
“In young individuals, light exposure at 6500 K significantly attenuated the increase in endogenous melatonin levels”
Human trialyoung adults; compared with non-blue-enriched light6500 K~40 lx2 hn = 31
Age-related neuroendocrine and alerting responses to light
GeroScience